Federal Register / Vol. 75, No. 45 / Tuesday, March 9, 2010 / Notices 10807 

will also participate in daily workshops 

with their industry counterparts, 

focusing on selective regulatory issues 

important to both CDER staff and 

industry. The primary objective of the 

daily workshops is to learn about the 

team approach to drug development, 

including drug discovery, preclinical 

evaluation, tracking mechanisms, and 

regulatory submission operations. The 

overall benefit to regulatory project 

managers will be exposure to project 

management, team techniques, and 

processes employed by the 

pharmaceutical industry. By 

participating in this program, the 

regulatory project manager will grow 

professionally by gaining a better 

understanding of industry processes and 

procedures 

III. Site Selection 

All travel expenses associated with 

the site tours will be the responsibility 

of CDER; therefore, selection will be 

based on the availability of funds and 

resources for each fiscal year. Selection 

will also be based on firms having a 

favorable facility status as determined 

by FDA’s Office of Regulatory Affairs 

District Offices in the firms’ respective 

regions. Firms interested in offering a 

site tour or learning more about this 

training opportunity should respond by 

(see DATES) by submitting a proposed 

agenda to Beth Duvall-Miller (see FOR

FURTHER INFORMATION CONTACT). 

Dated: March 3, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–4924 Filed 3–8–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism, Special 

Emphasis Panel, Member Conflicts SEP. 

Date: April 22, 2010. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIAAA, 5635 Fishers, Rockville, MD 

20852. 

Contact Person: Lorraine Gunzerath, PhD, 

MBA, Scientific Review Officer, National 

Institute on Alcohol Abuse and Alcoholism, 

Office of Extramural Activities, Extramural 

Project Review Branch, 5635 Fishers Lane, 

Room 2121, Bethesda, MD 20892–9304, 301– 

443–2369, lgunzera@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: February 26, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–4586 Filed 3–8–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Reviews 

(SPR), Advisory Board on Radiation 

and Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 9:30 a.m.–5 p.m., March 

23, 2010. 

Place: Cincinnati Airport Marriott, 2395 

Progress Drive, Hebron, Kentucky 41018, 

Telephone: (859) 334–4611, Fax: (859) 334– 

4619. 

Status: Open to the public, but without a 

public comment period. To access by 

conference call dial the following 

information 1(866) 659–0537, Participant 

Pass Code 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that have 

been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to CDC. 

NIOSH implements this responsibility for 

CDC. The charter was issued on August 3, 

2001, renewed at appropriate intervals, and 

will expire on August 3, 2011. 

Purpose: The Advisory Board is charged 

with (a) Providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. The Subcommittee on Procedures 

Reviews was established to aid the Advisory 

Board in carrying out its duty to advise the 

Secretary, HHS, on dose reconstruction. It is 

responsible for overseeing, tracking, and 

participating in the reviews of all procedures 

used in the dose reconstruction process by 

the NIOSH Office of Compensation Analysis 

and Support (OCAS) and its dose 

reconstruction contractor. 

Matters To Be Discussed: The agenda for 

the Subcommittee meeting includes: the 

development of recommendations for an 

Advisory Board procedure for reviewing 

OCAS Program Evaluation Reports; and 

discussion of the following Oak Ridge 

Associated Universities & OCAS procedures: 

OTIB–013 (‘‘Special External Dose 

Reconstruction Considerations for 

Mallinckrodt Workers’’), OTIB–014 (‘‘Rocky 

Flats Internal Dosimetry Co-Worker 

Extension’’), OTIB–0029 (‘‘Internal Dosimetry 

Coworker Data for Y–12’’), OTIB–0049 

(‘‘Estimating Doses for Plutonium Strongly 

Retained in the Lung’’), OTIB–0047 (External 

Radiation Monitoring at the Y–12 Facility 

During the 1948–1949 Period’’), OTIB–0051 

(‘‘Effect of Threshold Energy and Angular 

Response of NTA Film on Missed Neutron 

Dose at the Oak Ridge Y–12 Facility’’), OTIB– 

0054 (‘‘Fission and Activation Product 

Assignment for Internal Dose-Related Gross 

Beta and Gross Gamma Analyses’’), and 

OTIB–0070 (‘‘Dose Reconstruction During 

Residual Radioactivity Periods at Atomic 

Weapons Employer Facilities’’); and a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 


sroberts on DSKD5P82C1PROD with NOTICES